Understanding the effects of decriminalizing non-prescribed buprenorphine in Rhode Island
Evaluating the decriminalization of non-prescribed buprenorphine in Rhode Island
This study looks at how making non-prescribed buprenorphine legal in Rhode Island might help people with opioid use disorder, especially those who can't get traditional treatment, by exploring how they use this medication and what effects it has on their recovery.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-10676209 on NIH RePORTER |
What this research studies
This research investigates the impact of decriminalizing non-prescribed buprenorphine (NPB) in Rhode Island, focusing on how it affects individuals' use of this medication for treating opioid use disorder (OUD). The study aims to evaluate both formal treatment participation and self-treatment practices among individuals who may not have access to traditional treatment options. By analyzing consumption patterns and outcomes, the research seeks to provide insights into the potential benefits and risks associated with NPB use in the context of the ongoing overdose crisis.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in Rhode Island who are using or considering using non-prescribed buprenorphine for opioid use disorder.
Not a fit: Patients who are not affected by opioid use disorder or those who are already engaged in comprehensive formal treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could inform policies that improve access to effective treatments for opioid use disorder and reduce overdose deaths.
How similar studies have performed: While the decriminalization of non-prescribed buprenorphine is a relatively novel approach, similar initiatives in other states have shown promise in reducing overdose rates and improving access to treatment.
Where this research is happening
Providence, United States
- Rhode Island Hospital — Providence, United States (Active)
Researchers
- Principal investigator: Del Pozo, Brandon — Rhode Island Hospital
- Study coordinator: Del Pozo, Brandon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.